These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5220247)

  • 21. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative studies on various antituberculosis chemotherapies--from the results of the Tuberculosis Research Committee (Ryoken).
    Gomi J
    Jpn J Tuberc; 1966 Dec; 13():96-105. PubMed ID: 4166383
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mode of action of "tuverculostatics". Consequences for the therapy].
    Krebs A
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):208-17. PubMed ID: 4973006
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 25. Ethambutol in the initial treatment of pulmonary tuberculosis. U.S. Public Health Service tuberculosis therapy trials.
    Doster B; Murray FJ; Newman R; Woolpert SF
    Am Rev Respir Dis; 1973 Feb; 107(2):177-90. PubMed ID: 4567069
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethambutol compared to streptomycin in original treatment of advanced pulmonary tuberculosis.
    Bobrowitz ID
    Chest; 1971 Jul; 60(1):14-21. PubMed ID: 4255171
    [No Abstract]   [Full Text] [Related]  

  • 27. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
    Neumann G
    Wien Med Wochenschr; 1972 Dec; 122(51):764-8. PubMed ID: 4346497
    [No Abstract]   [Full Text] [Related]  

  • 28. Intermittent chemotherapy or improvement of initial treatment in tuberculosis.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination treatment with capreomycin of pretreated cavernous pulmonary tuberculosis.
    Kittel H
    Antibiot Chemother; 1970; 16():36-42. PubMed ID: 4108894
    [No Abstract]   [Full Text] [Related]  

  • 30. [Internal medicine treatment of pulmonary tuberculosis].
    Schaich W
    Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
    [No Abstract]   [Full Text] [Related]  

  • 31. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 32. [[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
    Kekkaku; 1971 Aug; 46(8):325-33. PubMed ID: 4998863
    [No Abstract]   [Full Text] [Related]  

  • 33. [Proceedings: Ambulatory chemotherapy of tuberculosis in Finland (organization)].
    Pätiälä J; Tani P
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):123-8. PubMed ID: 4128939
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of efficiency of large and small doses of isoniazid in combined treatment in pulmonary tuberculosis].
    Mysakowska H; Grodzki S; Przemyska B; Szarewicz W; Srednicka D
    Pol Tyg Lek; 1965 Apr; 20(16):562-4. PubMed ID: 5834844
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation.
    Pyle MM
    Ann N Y Acad Sci; 1966 Apr; 135(2):835-45. PubMed ID: 5220243
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1974 Jul; 110(1):95-8. PubMed ID: 4209360
    [No Abstract]   [Full Text] [Related]  

  • 39. Ethambutol in unresponsive childhood tuberculosis.
    Mankodi NA; Amdekar YK; Desai AG; Patel BD; Raichur GS
    Indian Pediatr; 1970 Apr; 7(4):202-11. PubMed ID: 5311828
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. I. Role of individual antituberculous drugs in drug regimens used in the chemotherapy of human tuberculosis.
    Trnka L; Tousek J
    Chemotherapy; 1974; 20(3):165-76. PubMed ID: 4136827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.